Pfizer’s $25.5 Million Effexor XR Antitrust Settlement Marks Turning Point in Long-standing Legal Battle
The Effexor XR Antitrust Litigation, centered around allegations of collusion between pharmaceutical giant Pfizer’s predecessor, Wyeth, and competitor Teva, has taken a significant turn with Pfizer’s agreement to a $25.5 million settlement. This settlement aims to address claims of conspiring to delay the release of a more affordable generic version of the widely-used antidepressant Effexor […]
Continue Reading